
Privia Health Group (PRVA) Gets a Buy from RBC Capital

RBC Capital analyst Sean Dodge initiated coverage on Privia Health Group with a Buy rating and a $30 price target. The stock closed at $24.22. Canaccord Genuity also issued a Buy rating, while Barclays maintained a Hold rating. Dodge is ranked #9888 out of 10072 analysts on TipRanks.
RBC Capital analyst Sean Dodge initiated coverage with a Buy rating on Privia Health Group on November 12 and set a price target of $30.00. The company’s shares closed yesterday at $24.22.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
According to TipRanks, Dodge is ranked #9888 out of 10072 analysts.
In addition to RBC Capital, Privia Health Group also received a Buy from Canaccord Genuity’s Richard Close in a report issued on November 11. However, on November 7, Barclays maintained a Hold rating on Privia Health Group (NASDAQ: PRVA).

